Hemlibra

Active substance

Holder

Status

Closed

Indication

Routine prophylaxis of bleeding episodes in patients with severe haemophilia A without factor VIII inhibitors and with inadequate response on their current treatment.

Public documents

Approbation

Information for the patient

Informed consent

Last update